Taniai T, Haruki K, Shiba H, Onda S, Sakamoto T, Yanaga K. Simultaneous resection for synchronous double primary cancers of the pancreas and the liver. Case Rep Gastroenterol. 2018;12(2):504–12.
Article
Google Scholar
Gerdes B, Ziegler A, Ramaswamy A, Wild A, Langer P, Bartsch DK. Multiple primaries in pancreatic cancer patients: indicator of a genetic predisposition? Int J Epidemiol. 2000;29(6):999–1003.
Article
CAS
Google Scholar
Tagawa T, Ito K, Fukuzawa K, Okamoto T, Fujinaga A, Kawasaki T, Masuda T, Iwaki K, Terashi T, Okamoto M, Shiromizu A, Motohiro A, Maehara Y. Surgical outcomes of non-small cell lung cancer in patients with a history of pancreaticobiliary cancer. Anticancer Res. 2017;37(6):3307–9.
PubMed
Google Scholar
Nanashima A, Kondo H, Nakashima M, Abo T, Arai J, Ishii M, Hidaka S, Kunizaki M, To K, Takeshita H, Yamasaki N, Tsuchiya T, Nagayasu T. Clinicopathological characteristics of multiple primary cancers in hepatobiliary and pancreas malignancies. Anticancer Res. 2015;35(2):1073–83.
PubMed
Google Scholar
Yamamura K, Hashimoto D, Kitano Y, Kuroda D, Eto T, Arima K, Kaida T, Miyata T, Nakagawa S, Imai K, Yamashita YI, Chikamoto A, Matsumura F, Baba H. Multiple primary cancers in patients with pancreatic cancer. Am Surg. 2018;84(12):e514–6.
Article
Google Scholar
Shin SJ, Park H, Sung YN, Yoo C, Hwang DW, Park JH, Kim KP, Lee SS, Ryoo BY, Seo DW, Kim SC, Hong SM. Prognosis of pancreatic cancer patients with synchronous or metachronous malignancies from other organs is better than those with pancreatic cancer only. Cancer Res Treat. 2018;50(4):1175–85.
Article
Google Scholar
Satiya J, Girotra M. A Rare Double Primary Tumor of the Pancreas and the Esophagus. Cureus. 2019;11(6):e4955.
PubMed
PubMed Central
Google Scholar
Trede M, Schwall G. The complications of pancreatectomy. Ann Surg. 1988;207(1):39–47.
Article
CAS
Google Scholar
Suker M, Beumer BR, Sadot E, Marthey L, Faris JE, Mellon EA, El-Rayes BF, Wang-Gillam A, Lacy J, Hosein PJ, Moorcraft SY, Conroy T, Hohla F, Allen P, Taieb J, Hong TS, Shridhar R, Chau I, van Eijck CH, Koerkamp BG. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. Lancet Oncol. 2016;17(6):801–10.
Article
CAS
Google Scholar
Reni M, Balzano G, Zanon S, Passoni P, Nicoletti R, Arcidiacono PG, Pepe G, Doglioni C, Fugazza C, Ceraulo D, Falconi M, Gianni L. Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma. Br J Cancer. 2016;115(3):290–6.
Article
CAS
Google Scholar
Evans DB, Rich TA, Byrd DR, Cleary KR, Connelly JH, Levin B, Charnsangavej C, Fenoglio CJ, Ames FC. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg. 1992;127(11):1335–9.
Article
CAS
Google Scholar
Warren SGO. Multiple primary malignant tumors: a survey of the literature and statistical study. Am J Cancer. 1932;16:1358–414.
Google Scholar
Siegel RL, Jemal A, Wender RC, Gansler T, Ma J, Brawley OW. An assessment of progress in cancer control. CA Cancer J Clin. 2018;68(5):329–39.
Article
Google Scholar
Bourgade S, de la Fouchardière C, Bennouna J, Bachet JB, Khemissa-Akouz F, Péré-Vergé D, Delbaldo C, Assenat E, Chauffert B, Michel P, Montoto-Grillot C, Ducreux M, Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817–25.
Article
Google Scholar
Muranaka T, Kuwatani M, Komatsu Y, Sawada K, Nakatsumi H, Kawamoto Y, Yuki S, Kubota Y, Kubo K, Kawahata S, Kawakubo K, Kawakami H, Sakamoto N. Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer. J Gastrointest Oncol. 2017;8(3):566–71.
Article
Google Scholar
Riall TS, Stager VM, Nealon WH, Townsend CM Jr, Kuo YF, Goodwin JS, Freeman JL. Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas. J Am Coll Surg. 2007;204(5):803–13 (discussion 13–4).
Article
Google Scholar
Hackert T, Tjaden C, Müller S, Hinz U, Hartwig W, Strobel O, Fritz S, Schmied B, Büchler MW, Werner J. Extrapancreatic malignancies in patients with pancreatic cancer: epidemiology and clinical consequences. Pancreas. 2012;41(2):212–7.
Article
Google Scholar
Lubezky N, Ben-Haim M, Lahat G, Marmor S, Solar I, Brazowski E, Nackache R, Klausner JM. Intraductal papillary mucinous neoplasm of the pancreas: associated cancers, family history, genetic predisposition? Surgery. 2012;151(1):70–5.
Article
Google Scholar
Ueda N, Nagakawa T, Ohta T, Kayahara M, Ueno K, Konishi I, Izumi R, Miyazaki I. Synchronous cancer of the biliary tract and pancreas associated with anomalous arrangement of the pancreaticobiliary ductal system. J Clin Gastroenterol. 1992;15(2):136–41.
Article
CAS
Google Scholar
Fujimori N, Nakamura T, Oono T, Igarashi H, Takahata S, Nakamura M, Tanaka M, Hayashi A, Aishima S, Ishigami K, Ogoshi K, Ito T, Takayanagi R. Adenocarcinoma involving the whole pancreas with multiple pancreatic masses. Intern Med. 2010;49(15):1527–32.
Article
Google Scholar
Sato K, Maekawa T, Yabuki K, Tamasaki Y, Maekawa H, Kudo K, et al. A case of triple synchronous cancers occurring in the gallbladder, common bile duct, and pancreas. J Gastroenterol. 2003;38(1):97–100.
Article
Google Scholar
Mizuno S, Isaji S, Ohsawa I, Kishiwada M, Hamada T, Usui M, Sakurai H, Tabata M. Pancreaticoduodenectomy with resection of the splenic artery and splenectomy for pancreatic double cancers after total gastrectomy. Preservation of the pancreatic function via the blood supply from the posterior epiploic artery: report of a case. Surg Today. 2012;42(5):482–8.
Article
Google Scholar
Desaki R, Mizuno S, Tanemura A, Kishiwada M, Murata Y, Azumi Y, Kuriyama N, Usui M, Sakurai H, Tabata M, Isaji S. A new surgical technique of pancreaticoduodenectomy with splenic artery resection for ductal adenocarcinoma of the pancreatic head and/or body invading splenic artery: impact of the balance between surgical radicality and QOL to avoid total pancreatectomy. Biomed Res Int. 2014;2014:219038.
Article
Google Scholar
Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, Anthony A, Corrie P, Falk S, Finch-Jones M, Wasan H, Ross P, Wall L, Wadsley J, Evans JTR, Stocken D, Praseedom R, Ma YT, Davidson B, Neoptolemos JP, Iveson T, Raftery J, Zhu S, Cunningham D, Garden OJ, Stubbs C, Valle JW, Bridgewater J, BILCAP study group. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20(5):663–73.
Article
CAS
Google Scholar